Kadcyla 160mg Injection is used in the treatment of early as well as metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines. Kadcyla 160mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include tiredness, nausea, musculoskeletal (bone, muscle or joint) pain, and bleeding. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. "There is a Patient Support Program / Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details."

• Nausea
• Musculoskeletal (bone, muscle or joint) pain
• Bleeding
• Low blood platelets
• Headache
• Liver disorder
• Constipation
• Nosebleeds

If you miss a dose of Kadcyla 160mg Injection, please consult your doctor.

• Q. Q. What is the use of Kadcyla 160mg Injection??
  Ans: Kadcyla 160mg Injection is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.
• Q. Q. How is Kadcyla 160mg Injection different??
  Ans: Kadcyla 160mg Injection is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Kadcyla 160mg Injection brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.
• Q. ?
  Ans:

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra